NSE · AI Signal & Stock Analysis · Bullish
As of Nov 13 2026, 6:15 AM, AkshayaAI's signal for ERIS is Bullish ↑ (mild move); technical trend down-trend; trading at ₹1,277.80 (+0.21% today); neutral (RSI 67). AkshayaAI's signal, trend and forecast for ERIS have been unchanged since 5 Nov 2026.
Data as of Nov 13 2026, 6:15 AM. Informational analytics only — not investment advice.
Instant, data-backed answers — free to try.
| AI signal | Bullish ↑ · Mild move |
|---|---|
| Technical trend | Down-trend (since 2026-07-22) |
| Price | ₹1,277.80 |
| Change today | +0.21% |
| RSI (14) | 66.60 |
| Relative volume | 0.62 |
| Composite (RMTPGV) score | 🔒 members |
| Market cap | ₹18,136 Cr |
| P/E | 25.42 |
| Cap category | Mid Cap |
| 52-week high | -24.5% away |
| 52-week low | +16.6% above |
| Delivery volume | — |
| Sector | Drug Manufacturers - Specialty & Generic |
As of Nov 13 2026, 6:15 AM, AkshayaAI's signal for ERIS (Eris Lifesciences Limited) is Bullish with a mild move, and its technical trend is down-trend. The composite score and full factor breakdown are available to signed-in members.
ERIS's RSI is neutral (RSI 67). A reading above 70 is typically overbought and below 30 oversold.
ERIS is trading about 24% below its 52-week high and 17% above its 52-week low as of Nov 13 2026, 6:15 AM.
ERIS's market capitalisation is ₹18,136 Cr as of Nov 13 2026, 6:15 AM.
ERIS is classified under Drug Manufacturers - Specialty & Generic in AkshayaAI's taxonomy.
AkshayaAI refreshes its signals daily. The figures on this page are timestamped as of the latest run shown above.
No. AkshayaAI provides informational, AI-generated analytics for ERIS — not personalised investment advice. Always do your own research.
AARTIPHARM · ABBOTINDIA · AJANTPHARM · AKUMS · ALIVUS · ALKEM
AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Nov 13 2026, 6:15 AM and may not reflect real-time prices. Always do your own research. How these signals work →